Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria

Lancet

Volumn 349, Issue 9068, 1997, Pages 1787-1792

  Chaturvedi, Nish ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCOSYLATED HEMOGLOBIN; INSULIN; LISINOPRIL; PLACEBO;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; DOUBLE BLIND PROCEDURE; EUROPE; FEMALE; HUMAN; HYPERTENSION; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; MICROALBUMINURIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE;

EID: 0030908772     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)10244-0     Document Type: Article

References (27)

1. Moss SE, Klein R, Klein BEK. Cause-specific mortality in a population-based study of diabetes. Am J Public Health 1991; 81: 1158-62.
2. Wang S-L, Head J, Stevens L, Fuller JH, WHO Multinational Study Group. Excess mortality and its relation to hypertension and proteinuria in diabetic patients: the WHO Multinational Study of Vascular Disease in Diabetes. Diabetes Care 1996; 19: 305-12.
3. Viberti GC, Hill RD, Jarrett R J, Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982; i: 1430-32.
4. Messent JWC, Elliott TG, Hill RD, Jarrett RJ, Keen H, Viberti G-C. Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up study. Kidney Int 1992; 41: 836-39.
5. Mogensen CE. Progression of nephropathy in long-term diabetics with proteinuria and effect of initial anti-hypertensive treatment. Scand J Clin Lab Invest 1976; 36: 383-88.
6. Kasiske BL, Kalil RSN, Ma JZ, Liao M, Keane WF. Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis. Ann Intern Med 1993; 118: 129-38.
7. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin converting enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 329: 1456-62.
8. Marre M, Chatellier G, Leblanc H, Guyene TT, Menard J, Passa P. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. BMJ 1988; 297: 1092-95.
9. Mathiesen ER, Hommel E, Giese J, Parving H-H. Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. BMJ 1991; 303: 81-87.
10. Passa P, Leblanc H, Marre M. Effects of enalapril in insulin dependent diabetic subjects with mild to moderate uncomplicated hypertension. Diabetes Care 1987; 10: 200-04.
11. Pedersen MM, Schmitz A, Pedersen EB, Danielsen H, Christiansen JS. Acute and long-term renal effects of angiotensin converting enzyme inhibition in normotensive, normoalbuminuric insulin-dependent diabetic patients. Diabet Med 1988; 5: 562-69.
12. Wiegmann TB, Herron KG, Chonko AM, MacDougall ML, Moore WV. Effect of angiotensin-converting enzyme inhibition on renal function and albuminuria in normotensive type I diabetic patients. Diabetes 1992; 41: 62-61.
13. Medcalf E, Newman DJ, German EG, Price CP. Rapid, robust method for measuring low concentrations of albumin in urine. Clin Chem 1990; 36 (3): 446-49.
14. John GW, Gray MR, Bates DL, Beacham JL. Enzyme immunoassay: a new technique for estimating HbA1c. Clin Chem 1933; 39: 663-66.
15. The EURODIAB IDDM Complications Study Group. Microvascular and acute complications in insulin dependent diabetes mellitus: the EURODIAB IDDM Complications Study. Diabetologia 1994; 37: 278-85.
16. Matthews JNS, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. BMJ 1990; 300: 230-35.
17. Laird NM, Wang F. Estimating rates of change in randomized clinical trials. Control Clin Trials 1990; 11: 405-19.
18. Frison L, Pocock SJ. Repeated measures in clinical trials: analysis using mean summary statistics and its implications for design. Stat Med 1992; 11: 1685-1704.
19. Mimran A, Insua A, Ribstein J, Bringer J, Monnier L. Comparative effect of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy. Diabetes Care 1988; 11: 850-53.
20. Viberti G, Mogensen CE, Groop LC, Pauls JF. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. JAMA 1994; 271: 275-79.
21. Laffel LMB, McGill JB, Gans DJ. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. Am J Med 1995; 99: 497-504.
22. The Microalbuminuria Captopril Study Group. Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria. Diabetologia 1996; 39: 587-93.
23. Pollare T, Lithell H, Berne C. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med 1989; 321: 868-73.
24. Paolisso G, Gambardella A, Verza M, D'Amore A, Sgambato S, Varricchio M. ACE inhibition improves insulin-sensitivity in aged insulin-resistant hypertension patients. J Hum Hyperten 1992; 6: 175-79.
25. Herings RMC, de Boer A, Stricker BHCh, Leufkens HGM, Porsius A. Hypoglycaemia associated with use of inhibitors of angiotensin converting enzyme. Lancet 1995; 345: 1195-98.
26. Donnelly R. Angiotensin-converting enzyme inhibitors and insulin sensitivity: metabolic effects in hypertension, diabetes, and heart failure. J Cardiovasc Pharmacol 1992; 20 (suppl 11): 38-44.
27. Petrie JR, Morris AD, Ueda S, et al. Do ACE inhibitors improve insulin sensitivity? Lancet 1995; 346: 583-84.